332 related articles for article (PubMed ID: 33935281)
1. ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4.
Liu J; Cao F; Li X; Zhang L; Liu Z; Li X; Lin J; Han C
Cell Death Dis; 2021 May; 12(5):438. PubMed ID: 33935281
[TBL] [Abstract][Full Text] [Related]
2. ITIH5, as a predictor of prognosis and immunotherapy response for P53-like bladder cancer, is related to cell proliferation and invasion.
Peng K; Ding D; Wang N; Du T; Wang L; Duan X
Mol Omics; 2023 Oct; 19(9):714-725. PubMed ID: 37431189
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the adaptation to ER stress by KLF4 facilitates melanoma cell metastasis via upregulating NUCB2 expression.
Zhang D; Lin J; Chao Y; Zhang L; Jin L; Li N; He R; Ma B; Zhao W; Han C
J Exp Clin Cancer Res; 2018 Jul; 37(1):176. PubMed ID: 30055641
[TBL] [Abstract][Full Text] [Related]
4. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.
Sasaki K; Kurahara H; Young ED; Natsugoe S; Ijichi A; Iwakuma T; Welch DR
Clin Exp Metastasis; 2017 Apr; 34(3-4):229-239. PubMed ID: 28289921
[TBL] [Abstract][Full Text] [Related]
6. ITIH5 mediates epigenetic reprogramming of breast cancer cells.
Rose M; Kloten V; Noetzel E; Gola L; Ehling J; Heide T; Meurer SK; Gaiko-Shcherbak A; Sechi AS; Huth S; Weiskirchen R; Klaas O; Antonopoulos W; Lin Q; Wagner W; Veeck J; Gremse F; Steitz J; Knüchel R; Dahl E
Mol Cancer; 2017 Feb; 16(1):44. PubMed ID: 28231808
[TBL] [Abstract][Full Text] [Related]
7. Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5.
Young ED; Manley SJ; Beadnell TC; Shearin AE; Sasaki K; Zimmerman R; Kauffman E; Vivian CJ; Parasuram A; Iwakuma T; Grandgenett PM; Hollingsworth MA; O'Neil M; Welch DR
Br J Cancer; 2021 Jan; 124(1):166-175. PubMed ID: 33024269
[TBL] [Abstract][Full Text] [Related]
8. Gene expression analysis combined with functional genomics approach identifies ITIH5 as tumor suppressor gene in cervical carcinogenesis.
Dittmann J; Ziegfeld A; Jansen L; Gajda M; Kloten V; Dahl E; Runnebaum IB; Dürst M; Backsch C
Mol Carcinog; 2017 Jun; 56(6):1578-1589. PubMed ID: 28059468
[TBL] [Abstract][Full Text] [Related]
9. Inter-α-trypsin inhibitor heavy chain 5 (ITIH5) is overexpressed in inflammatory skin diseases and affects epidermal morphology in constitutive knockout mice and murine 3D skin models.
Huth S; Heise R; Vetter-Kauczok CS; Skazik C; Marquardt Y; Czaja K; Knüchel R; Merk HF; Dahl E; Baron JM
Exp Dermatol; 2015 Sep; 24(9):663-8. PubMed ID: 25809190
[TBL] [Abstract][Full Text] [Related]
10. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
Zhu Z; Yu Z; Wang J; Zhou L; Zhang J; Yao B; Dou J; Qiu Z; Huang C
Cell Physiol Biochem; 2018; 46(1):238-252. PubMed ID: 29587259
[TBL] [Abstract][Full Text] [Related]
11. Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
Mai C; Zhao JJ; Tang XF; Wang W; Pan K; Pan QZ; Zhang XF; Jiang SS; Zhao BW; Li YF; Xia JC; Zhou ZW
Med Oncol; 2014 Jul; 31(7):53. PubMed ID: 24913813
[TBL] [Abstract][Full Text] [Related]
12. Krüppel-like factor 4 promotes human osteosarcoma growth and metastasis via regulating CRYAB expression.
Zhang L; Zhang L; Xia X; He S; He H; Zhao W
Oncotarget; 2016 May; 7(21):30990-1000. PubMed ID: 27105535
[TBL] [Abstract][Full Text] [Related]
13. ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.
Rose M; Meurer SK; Kloten V; Weiskirchen R; Denecke B; Antonopoulos W; Deckert M; Knüchel R; Dahl E
Mol Carcinog; 2018 Feb; 57(2):167-181. PubMed ID: 28940371
[TBL] [Abstract][Full Text] [Related]
14. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
[TBL] [Abstract][Full Text] [Related]
15. The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells.
Rose M; Noetzel E; Kistermann J; Eschenbruch J; Rushrush S; Gan L; Knüchel R; Gaisa NT; Dahl E
Cells; 2021 Apr; 10(5):. PubMed ID: 33924987
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.
Rose M; Gaisa NT; Antony P; Fiedler D; Heidenreich A; Otto W; Denzinger S; Bertz S; Hartmann A; Karl A; Knüchel R; Dahl E
Carcinogenesis; 2014 Mar; 35(3):727-36. PubMed ID: 24265292
[TBL] [Abstract][Full Text] [Related]
17. ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer.
Himmelfarb M; Klopocki E; Grube S; Staub E; Klaman I; Hinzmann B; Kristiansen G; Rosenthal A; Dürst M; Dahl E
Cancer Lett; 2004 Feb; 204(1):69-77. PubMed ID: 14744536
[TBL] [Abstract][Full Text] [Related]
18. Inter-α-Trypsin Inhibitor Heavy Chain 5 (ITIH5) Is a Natural Stabilizer of Hyaluronan That Modulates Biological Processes in the Skin.
Huth S; Huth L; Marquardt Y; Fietkau K; Dahl E; Esser PR; Martin SF; Heise R; Merk HF; Baron JM
Skin Pharmacol Physiol; 2020; 33(4):198-206. PubMed ID: 32799206
[TBL] [Abstract][Full Text] [Related]
19. ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration.
Kosinski J; Sechi A; Hain J; Villwock S; Ha SA; Hauschulz M; Rose M; Steib F; Ortiz-Brüchle N; Heij L; Maas SL; van der Vorst EPC; Knoesel T; Altendorf-Hofmann A; Simon R; Sauter G; Bednarsch J; Jonigk D; Dahl E
Mol Oncol; 2024 Jun; 18(6):1486-1509. PubMed ID: 38375974
[TBL] [Abstract][Full Text] [Related]
20. KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.
Riverso M; Montagnani V; Stecca B
Oncogene; 2017 Jun; 36(23):3322-3333. PubMed ID: 28068326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]